SEC Form 4 · accession 0001209191-18-061652
KYNTRA BIO, INC. · KYNB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Maykin Ho
Director
Period of report
Dec 5, 2018
Accepted (ET)
Dec 7, 2018 · 6:51 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000921299
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 5, 2018 | A | 1,855 | $0.00 | A | 1,855 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $41.34 | Dec 5, 2018 | A | 10,400 | A | — | Dec 5, 2028 | Common Stock | 10,400 | 10,400 | D |
| Stock Option (Right to Buy)F3 | $41.34 | Dec 5, 2018 | A | 3,008 | A | — | Dec 5, 2028 | Common Stock | 3,008 | 3,008 | D |
Explanation of responses
- F1Represents the grant of restricted stock units that vest on the earlier of June 6, 2019 or the date of the next annual meeting of stockholders.
- F2Option vests quarterly over three years from December 5, 2018.
- F3Options vest on the earlier of June 6, 2019 or the date of next annual meeting of stockholders.